カテゴリー： 世界, 医療/バイオ, QYResearch

トラメチニブの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Trametinib Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10504）・商品コード：QY22JLX10504
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：72
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、トラメチニブのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にトラメチニブの世界市場のxxx％を占める「200mg」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「切除不能悪性黒色腫」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
トラメチニブの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのトラメチニブ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

トラメチニブのグローバル主要企業には、Novartis、GlaxoSmithKlineなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

トラメチニブ市場は、種類と用途によって区分されます。世界のトラメチニブ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
200mg、300mg、その他

【用途別セグメント】
切除不能悪性黒色腫、転移性悪性黒色腫、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- トラメチニブ製品概要
- 種類別市場（200mg、300mg、その他）
- 用途別市場（切除不能悪性黒色腫、転移性悪性黒色腫、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のトラメチニブ販売量予測2017-2028
- 世界のトラメチニブ売上予測2017-2028
- トラメチニブの地域別販売量
- トラメチニブの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別トラメチニブ販売量
- 主要メーカー別トラメチニブ売上
- 主要メーカー別トラメチニブ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（200mg、300mg、その他）
- トラメチニブの種類別販売量
- トラメチニブの種類別売上
- トラメチニブの種類別価格
・用途別市場規模（切除不能悪性黒色腫、転移性悪性黒色腫、その他）
- トラメチニブの用途別販売量
- トラメチニブの用途別売上
- トラメチニブの用途別価格
・北米市場
- 北米のトラメチニブ市場規模（種類別、用途別）
- 主要国別のトラメチニブ市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのトラメチニブ市場規模（種類別、用途別）
- 主要国別のトラメチニブ市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のトラメチニブ市場規模（種類別、用途別）
- 主要国別のトラメチニブ市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のトラメチニブ市場規模（種類別、用途別）
- 主要国別のトラメチニブ市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのトラメチニブ市場規模（種類別、用途別）
- 主要国別のトラメチニブ市場規模（トルコ、サウジアラビア）
・企業情報
Novartis、GlaxoSmithKline
・産業チェーン及び販売チャネル分析
- トラメチニブの産業チェーン分析
- トラメチニブの原材料
- トラメチニブの生産プロセス
- トラメチニブの販売及びマーケティング
- トラメチニブの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- トラメチニブの産業動向
- トラメチニブのマーケットドライバー
- トラメチニブの課題
- トラメチニブの阻害要因
・主な調査結果

Market Analysis and Insights: Global Trametinib Market
Due to the COVID-19 pandemic, the global Trametinib market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, 200 mg accounting for % of the Trametinib global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Unresectable Melanoma segment is altered to an % CAGR throughout this forecast period.
China Trametinib market size is valued at US$ million in 2021, while the US and Europe Trametinib are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Trametinib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Trametinib include Novartis and GlaxoSmithKline etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Trametinib Scope and Segment
Trametinib market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Trametinib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
200 mg
300 mg
Other
Segment by Application
Unresectable Melanoma
Metastatic Melanoma
Other
By Company
Novartis
GlaxoSmithKline
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Trametinib Product Introduction
1.2 Market by Type
1.2.1 Global Trametinib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 200 mg
1.2.3 300 mg
1.2.4 Other
1.3 Market by Application
1.3.1 Global Trametinib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Trametinib Sales Estimates and Forecasts 2017-2028
2.2 Global Trametinib Revenue Estimates and Forecasts 2017-2028
2.3 Global Trametinib Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Trametinib Sales by Region
2.4.1 Global Trametinib Sales by Region (2017-2022)
2.4.2 Global Sales Trametinib by Region (2023-2028)
2.5 Global Trametinib Revenue by Region
2.5.1 Global Trametinib Revenue by Region (2017-2022)
2.5.2 Global Trametinib Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Trametinib Sales by Manufacturers
3.1.1 Global Top Trametinib Manufacturers by Sales (2017-2022)
3.1.2 Global Trametinib Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Trametinib in 2021
3.2 Global Trametinib Revenue by Manufacturers
3.2.1 Global Trametinib Revenue by Manufacturers (2017-2022)
3.2.2 Global Trametinib Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Trametinib Revenue in 2021
3.3 Global Trametinib Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Trametinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Trametinib Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Trametinib Sales by Type
4.1.1 Global Trametinib Historical Sales by Type (2017-2022)
4.1.2 Global Trametinib Forecasted Sales by Type (2023-2028)
4.1.3 Global Trametinib Sales Market Share by Type (2017-2028)
4.2 Global Trametinib Revenue by Type
4.2.1 Global Trametinib Historical Revenue by Type (2017-2022)
4.2.2 Global Trametinib Forecasted Revenue by Type (2023-2028)
4.2.3 Global Trametinib Revenue Market Share by Type (2017-2028)
4.3 Global Trametinib Price by Type
4.3.1 Global Trametinib Price by Type (2017-2022)
4.3.2 Global Trametinib Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Trametinib Sales by Application
5.1.1 Global Trametinib Historical Sales by Application (2017-2022)
5.1.2 Global Trametinib Forecasted Sales by Application (2023-2028)
5.1.3 Global Trametinib Sales Market Share by Application (2017-2028)
5.2 Global Trametinib Revenue by Application
5.2.1 Global Trametinib Historical Revenue by Application (2017-2022)
5.2.2 Global Trametinib Forecasted Revenue by Application (2023-2028)
5.2.3 Global Trametinib Revenue Market Share by Application (2017-2028)
5.3 Global Trametinib Price by Application
5.3.1 Global Trametinib Price by Application (2017-2022)
5.3.2 Global Trametinib Price Forecast by Application (2023-2028)
6 North America
6.1 North America Trametinib Market Size by Type
6.1.1 North America Trametinib Sales by Type (2017-2028)
6.1.2 North America Trametinib Revenue by Type (2017-2028)
6.2 North America Trametinib Market Size by Application
6.2.1 North America Trametinib Sales by Application (2017-2028)
6.2.2 North America Trametinib Revenue by Application (2017-2028)
6.3 North America Trametinib Market Size by Country
6.3.1 North America Trametinib Sales by Country (2017-2028)
6.3.2 North America Trametinib Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Trametinib Market Size by Type
7.1.1 Europe Trametinib Sales by Type (2017-2028)
7.1.2 Europe Trametinib Revenue by Type (2017-2028)
7.2 Europe Trametinib Market Size by Application
7.2.1 Europe Trametinib Sales by Application (2017-2028)
7.2.2 Europe Trametinib Revenue by Application (2017-2028)
7.3 Europe Trametinib Market Size by Country
7.3.1 Europe Trametinib Sales by Country (2017-2028)
7.3.2 Europe Trametinib Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Trametinib Market Size by Type
8.1.1 Asia Pacific Trametinib Sales by Type (2017-2028)
8.1.2 Asia Pacific Trametinib Revenue by Type (2017-2028)
8.2 Asia Pacific Trametinib Market Size by Application
8.2.1 Asia Pacific Trametinib Sales by Application (2017-2028)
8.2.2 Asia Pacific Trametinib Revenue by Application (2017-2028)
8.3 Asia Pacific Trametinib Market Size by Region
8.3.1 Asia Pacific Trametinib Sales by Region (2017-2028)
8.3.2 Asia Pacific Trametinib Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Trametinib Market Size by Type
9.1.1 Latin America Trametinib Sales by Type (2017-2028)
9.1.2 Latin America Trametinib Revenue by Type (2017-2028)
9.2 Latin America Trametinib Market Size by Application
9.2.1 Latin America Trametinib Sales by Application (2017-2028)
9.2.2 Latin America Trametinib Revenue by Application (2017-2028)
9.3 Latin America Trametinib Market Size by Country
9.3.1 Latin America Trametinib Sales by Country (2017-2028)
9.3.2 Latin America Trametinib Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Trametinib Market Size by Type
10.1.1 Middle East and Africa Trametinib Sales by Type (2017-2028)
10.1.2 Middle East and Africa Trametinib Revenue by Type (2017-2028)
10.2 Middle East and Africa Trametinib Market Size by Application
10.2.1 Middle East and Africa Trametinib Sales by Application (2017-2028)
10.2.2 Middle East and Africa Trametinib Revenue by Application (2017-2028)
10.3 Middle East and Africa Trametinib Market Size by Country
10.3.1 Middle East and Africa Trametinib Sales by Country (2017-2028)
10.3.2 Middle East and Africa Trametinib Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Trametinib Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Trametinib Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Overview
11.2.3 GlaxoSmithKline Trametinib Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GlaxoSmithKline Trametinib Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GlaxoSmithKline Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Trametinib Industry Chain Analysis
12.2 Trametinib Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Trametinib Production Mode & Process
12.4 Trametinib Sales and Marketing
12.4.1 Trametinib Sales Channels
12.4.2 Trametinib Distributors
12.5 Trametinib Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Trametinib Industry Trends
13.2 Trametinib Market Drivers
13.3 Trametinib Market Challenges
13.4 Trametinib Market Restraints
14 Key Findings in The Global Trametinib Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Trametinib Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 200 mg
Table 3. Major Manufacturers of 300 mg
Table 4. Major Manufacturers of Other
Table 5. Global Trametinib Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Trametinib Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Trametinib Sales by Region (2017-2022) & (M Pcs)
Table 8. Global Trametinib Sales Market Share by Region (2017-2022)
Table 9. Global Trametinib Sales by Region (2023-2028) & (M Pcs)
Table 10. Global Trametinib Sales Market Share by Region (2023-2028)
Table 11. Global Trametinib Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Trametinib Revenue Market Share by Region (2017-2022)
Table 13. Global Trametinib Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Trametinib Revenue Market Share by Region (2023-2028)
Table 15. Global Trametinib Sales by Manufacturers (2017-2022) & (M Pcs)
Table 16. Global Trametinib Sales Share by Manufacturers (2017-2022)
Table 17. Global Trametinib Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Trametinib Revenue Share by Manufacturers (2017-2022)
Table 19. Trametinib Price by Manufacturers (2017-2022) &(US$/Pcs)
Table 20. Global Trametinib Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Trametinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Trametinib as of 2021)
Table 22. Trametinib Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Trametinib Product Offered
Table 24. Date of Manufacturers Enter into Trametinib Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Trametinib Sales by Type (2017-2022) & (M Pcs)
Table 27. Global Trametinib Sales by Type (2023-2028) & (M Pcs)
Table 28. Global Trametinib Sales Share by Type (2017-2022)
Table 29. Global Trametinib Sales Share by Type (2023-2028)
Table 30. Global Trametinib Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Trametinib Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Trametinib Revenue Share by Type (2017-2022)
Table 33. Global Trametinib Revenue Share by Type (2023-2028)
Table 34. Trametinib Price by Type (2017-2022) & (US$/Pcs)
Table 35. Global Trametinib Price Forecast by Type (2023-2028) & (US$/Pcs)
Table 36. Global Trametinib Sales by Application (2017-2022) & (M Pcs)
Table 37. Global Trametinib Sales by Application (2023-2028) & (M Pcs)
Table 38. Global Trametinib Sales Share by Application (2017-2022)
Table 39. Global Trametinib Sales Share by Application (2023-2028)
Table 40. Global Trametinib Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Trametinib Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Trametinib Revenue Share by Application (2017-2022)
Table 43. Global Trametinib Revenue Share by Application (2023-2028)
Table 44. Trametinib Price by Application (2017-2022) & (US$/Pcs)
Table 45. Global Trametinib Price Forecast by Application (2023-2028) & (US$/Pcs)
Table 46. North America Trametinib Sales by Type (2017-2022) & (M Pcs)
Table 47. North America Trametinib Sales by Type (2023-2028) & (M Pcs)
Table 48. North America Trametinib Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Trametinib Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Trametinib Sales by Application (2017-2022) & (M Pcs)
Table 51. North America Trametinib Sales by Application (2023-2028) & (M Pcs)
Table 52. North America Trametinib Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Trametinib Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Trametinib Sales by Country (2017-2022) & (M Pcs)
Table 55. North America Trametinib Sales by Country (2023-2028) & (M Pcs)
Table 56. North America Trametinib Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Trametinib Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Trametinib Sales by Type (2017-2022) & (M Pcs)
Table 59. Europe Trametinib Sales by Type (2023-2028) & (M Pcs)
Table 60. Europe Trametinib Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Trametinib Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Trametinib Sales by Application (2017-2022) & (M Pcs)
Table 63. Europe Trametinib Sales by Application (2023-2028) & (M Pcs)
Table 64. Europe Trametinib Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Trametinib Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Trametinib Sales by Country (2017-2022) & (M Pcs)
Table 67. Europe Trametinib Sales by Country (2023-2028) & (M Pcs)
Table 68. Europe Trametinib Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Trametinib Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Trametinib Sales by Type (2017-2022) & (M Pcs)
Table 71. Asia Pacific Trametinib Sales by Type (2023-2028) & (M Pcs)
Table 72. Asia Pacific Trametinib Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Trametinib Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Trametinib Sales by Application (2017-2022) & (M Pcs)
Table 75. Asia Pacific Trametinib Sales by Application (2023-2028) & (M Pcs)
Table 76. Asia Pacific Trametinib Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Trametinib Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Trametinib Sales by Region (2017-2022) & (M Pcs)
Table 79. Asia Pacific Trametinib Sales by Region (2023-2028) & (M Pcs)
Table 80. Asia Pacific Trametinib Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Trametinib Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Trametinib Sales by Type (2017-2022) & (M Pcs)
Table 83. Latin America Trametinib Sales by Type (2023-2028) & (M Pcs)
Table 84. Latin America Trametinib Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Trametinib Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Trametinib Sales by Application (2017-2022) & (M Pcs)
Table 87. Latin America Trametinib Sales by Application (2023-2028) & (M Pcs)
Table 88. Latin America Trametinib Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Trametinib Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Trametinib Sales by Country (2017-2022) & (M Pcs)
Table 91. Latin America Trametinib Sales by Country (2023-2028) & (M Pcs)
Table 92. Latin America Trametinib Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Trametinib Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Trametinib Sales by Type (2017-2022) & (M Pcs)
Table 95. Middle East and Africa Trametinib Sales by Type (2023-2028) & (M Pcs)
Table 96. Middle East and Africa Trametinib Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Trametinib Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Trametinib Sales by Application (2017-2022) & (M Pcs)
Table 99. Middle East and Africa Trametinib Sales by Application (2023-2028) & (M Pcs)
Table 100. Middle East and Africa Trametinib Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Trametinib Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Trametinib Sales by Country (2017-2022) & (M Pcs)
Table 103. Middle East and Africa Trametinib Sales by Country (2023-2028) & (M Pcs)
Table 104. Middle East and Africa Trametinib Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Trametinib Revenue by Country (2023-2028) & (US$ Million)
Table 106. Novartis Corporation Information
Table 107. Novartis Description and Major Businesses
Table 108. Novartis Trametinib Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 109. Novartis Trametinib Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Novartis Recent Developments
Table 111. GlaxoSmithKline Corporation Information
Table 112. GlaxoSmithKline Description and Major Businesses
Table 113. GlaxoSmithKline Trametinib Sales (M Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2017-2022)
Table 114. GlaxoSmithKline Trametinib Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. GlaxoSmithKline Recent Developments
Table 116. Key Raw Materials Lists
Table 117. Raw Materials Key Suppliers Lists
Table 118. Trametinib Distributors List
Table 119. Trametinib Customers List
Table 120. Trametinib Market Trends
Table 121. Trametinib Market Drivers
Table 122. Trametinib Market Challenges
Table 123. Trametinib Market Restraints
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Trametinib Product Picture
Figure 3. Global Trametinib Market Share by Type in 2021 & 2028
Figure 3. 200 mg Product Picture
Figure 4. 300 mg Product Picture
Figure 5. Other Product Picture
Figure 6. Global Trametinib Market Share by Application in 2021 & 2028
Figure 7. Unresectable Melanoma
Figure 8. Metastatic Melanoma
Figure 9. Other
Figure 10. Trametinib Report Years Considered
Figure 11. Global Trametinib Sales 2017-2028 (M Pcs)
Figure 12. Global Trametinib Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Trametinib Revenue 2017-2028 (US$ Million)
Figure 14. Global Trametinib Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Trametinib Sales Market Share by Region (2017-2022)
Figure 16. Global Trametinib Sales Market Share by Region (2023-2028)
Figure 17. North America Trametinib Sales YoY (2017-2028) & (M Pcs)
Figure 18. North America Trametinib Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Trametinib Sales YoY (2017-2028) & (M Pcs)
Figure 20. Europe Trametinib Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Trametinib Sales YoY (2017-2028) & (M Pcs)
Figure 22. Asia-Pacific Trametinib Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Trametinib Sales YoY (2017-2028) & (M Pcs)
Figure 24. Latin America Trametinib Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Trametinib Sales YoY (2017-2028) & (M Pcs)
Figure 26. Middle East & Africa Trametinib Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Trametinib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Trametinib in the World: Market Share by Trametinib Revenue in 2021
Figure 29. Global Trametinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Trametinib Sales Market Share by Type (2017-2028)
Figure 31. Global Trametinib Revenue Market Share by Type (2017-2028)
Figure 32. Global Trametinib Sales Market Share by Application (2017-2028)
Figure 33. Global Trametinib Revenue Market Share by Application (2017-2028)
Figure 34. North America Trametinib Sales Market Share by Type (2017-2028)
Figure 35. North America Trametinib Revenue Market Share by Type (2017-2028)
Figure 36. North America Trametinib Sales Market Share by Application (2017-2028)
Figure 37. North America Trametinib Revenue Market Share by Application (2017-2028)
Figure 38. North America Trametinib Sales Share by Country (2017-2028)
Figure 39. North America Trametinib Revenue Share by Country (2017-2028)
Figure 40. United States Trametinib Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Trametinib Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Trametinib Sales Market Share by Type (2017-2028)
Figure 43. Europe Trametinib Revenue Market Share by Type (2017-2028)
Figure 44. Europe Trametinib Sales Market Share by Application (2017-2028)
Figure 45. Europe Trametinib Revenue Market Share by Application (2017-2028)
Figure 46. Europe Trametinib Sales Share by Country (2017-2028)
Figure 47. Europe Trametinib Revenue Share by Country (2017-2028)
Figure 48. Germany Trametinib Revenue (2017-2028) & (US$ Million)
Figure 49. France Trametinib Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Trametinib Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Trametinib Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Trametinib Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Trametinib Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Trametinib Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Trametinib Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Trametinib Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Trametinib Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Trametinib Revenue Share by Region (2017-2028)
Figure 59. China Trametinib Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Trametinib Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Trametinib Revenue (2017-2028) & (US$ Million)
Figure 62. India Trametinib Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Trametinib Revenue (2017-2028) & (US$ Million)
Figure 64. China Taiwan Trametinib Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Trametinib Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Trametinib Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Trametinib Revenue (2017-2028) & (US$ Million)
Figure 68. Latin America Trametinib Sales Market Share by Type (2017-2028)
Figure 69. Latin America Trametinib Revenue Market Share by Type (2017-2028)
Figure 70. Latin America Trametinib Sales Market Share by Application (2017-2028)
Figure 71. Latin America Trametinib Revenue Market Share by Application (2017-2028)
Figure 72. Latin America Trametinib Sales Share by Country (2017-2028)
Figure 73. Latin America Trametinib Revenue Share by Country (2017-2028)
Figure 74. Mexico Trametinib Revenue (2017-2028) & (US$ Million)
Figure 75. Brazil Trametinib Revenue (2017-2028) & (US$ Million)
Figure 76. Argentina Trametinib Revenue (2017-2028) & (US$ Million)
Figure 77. Middle East and Africa Trametinib Sales Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Trametinib Revenue Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Trametinib Sales Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Trametinib Revenue Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Trametinib Sales Share by Country (2017-2028)
Figure 82. Middle East and Africa Trametinib Revenue Share by Country (2017-2028)
Figure 83. Turkey Trametinib Revenue (2017-2028) & (US$ Million)
Figure 84. Saudi Arabia Trametinib Revenue (2017-2028) & (US$ Million)
Figure 85. UAE Trametinib Revenue (2017-2028) & (US$ Million)
Figure 86. Trametinib Value Chain
Figure 87. Trametinib Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed


★調査レポート[トラメチニブの世界市場インサイト・予測（～2028年）] (コード：QY22JLX10504)販売に関する免責事項を必ずご確認ください。
★調査レポート[トラメチニブの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • アジュバントペプチドの世界市場インサイト・予測（～2028年）
  • 結膜炎治療の世界市場インサイト・予測（～2028年）
  • ダラツムマブ注射の世界市場インサイト・予測（～2028年）
  • デノスマブの世界市場インサイト・予測（～2028年）
  • マイオビューの世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆